Displaying all 2 publications

Abstract:
Sort:
  1. Hung YT, Aziz HA, Ramli SF, Paul HH, Huhnke CR, Adesanmi BM
    Water Environ Res, 2020 Oct;92(10):1504-1509.
    PMID: 32659868 DOI: 10.1002/wer.1399
    This paper reviews the related literature reported in 2019 about various types of wastewaters associated with chemical and allied products. The subjects comprise wastewaters produced from various activities in agricultural, chemical, dye, petrochemical, and pharmaceutical. PRACTITIONER POINTS: Bioflocculant chitosan was used for sludge dewatering and the treatment of water and wastewater, and polishing of sanitary landfill leachate. Alkaline lignin-based flocculants were used to achieve excellent color removal for paper mill sludge. Powdered activated coke was used to remove COD (chemical oxygen demand) from chemical industry wastewater effluents.
  2. AlAama J, Smith TD, Lo A, Howard H, Kline AA, Lange M, et al.
    Hum Mutat, 2011 May;32(5):501-6.
    PMID: 21305654 DOI: 10.1002/humu.21463
    Genetic diseases are a pressing global health problem that requires comprehensive access to basic clinical and genetic data to counter. The creation of regional and international databases that can be easily accessed by clinicians and diagnostic labs will greatly improve our ability to accurately diagnose and treat patients with genetic disorders. The Human Variome Project is currently working in conjunction with human genetics societies to achieve this by establishing systems to collect every mutation reported by a diagnostic laboratory, clinic, or research laboratory in a country and store these within a national repository, or HVP Country Node. Nodes have already been initiated in Australia, Belgium, China, Egypt, Malaysia, and Kuwait. Each is examining how to systematically collect and share genetic, clinical, and biochemical information in a country-specific manner that is sensitive to local ethical and cultural issues. This article gathers cases of genetic data collection within countries and takes recommendations from the global community to develop a procedure for countries wishing to establish their own collection system as part of the Human Variome Project. We hope this may lead to standard practices to facilitate global collection of data and allow efficient use in clinical practice, research and therapy.
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links